Lijun Liu

10PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersMolecular targetsCardiology (incl. cardiovascular diseases)Epigenetics (incl. genome methylation and epigenomics)Autonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 31, 2026
Glucocorticoid-Modulated Molecular Signatures and Prediction of Treatment Efficacy in IgA Nephropathy.

|Apr 08, 2026
Endothelin Receptor Antagonist Ambrisentan, Sodium-Glucose Cotransporter 2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy: A Randomized Crossover Trial.

Qinlan Chen, Pei Chen, Lijun Liu

|Jan 21, 2026
CFHR3*B Haplotype, Complement Activation, and Risk of IgA Nephropathy.

Yongji Zhang, Honghong Zou, Xinran Ni

|Jan 21, 2026
Genetic Determinants of Steroid Responsiveness in IgA Nephropathy.

Lin-Lin Xu, Xu-Jie Zhou, Wenjian Bi

|Apr 01, 2025
Effectiveness and safety of finerenone in non-diabetic patients with IgA nephropathy.

Chen Tang, Feng-Lei Si, Pei Chen

|Aug 22, 2024
Lactobacillus casei Cell Wall Extract and Production of Galactose-Deficient IgA1 in a Humanized IGHA1 Mouse Model.

Run Li, Manliu Wang, Jingyi Li

Pageof 2

Frequent Collaborators

6 joint publications

Sufang Shi

5 joint publications

Xujie Zhou

4 joint publications

Li Zhu

3 joint publications

Hong Zhang